Biography
Dr Michael Hsieh is passionate about delivering the best possible care to his patients by employing the latest advancements in radiation therapy and maintaining a multidisciplinary approach. He believes in empowering patients and ensuring they feel in control of their treatment every step of the way.
Dr Michael Hsieh is a dedicated Radiation Oncologist at Icon Cancer Centre Geelong and Warrnambool. He completed his Bachelor of Medicine, Bachelor of Surgery (MBBS) and Bachelor of Science (BSc) at the University of Queensland in 2013. Dr Hsieh undertook his specialist training in radiation oncology across several prominent healthcare institutions, including New South Wales Health, Gosford and Coffs Harbour, and the Austin Health and Peter MacCallum Cancer Centre, Melbourne. Dr Hsieh became a Fellow of the Royal Australian and New Zealand College of Radiologists (FRANZCR) in 2024 and is amember of the Trans-Tasman Radiation Oncology Group (TROG) and Australian and New Zealand Head and Neck Cancer Society (ANZHNCS). He has also been recognised for his academic excellence, receiving the CE Eddy Prize in 2020 for his success in the RANZCR Part 1 examinations.
He has authored several peer-reviewed publications, contributing to advances in radiation oncology, including research on radiation techniques for complex cancer cases. In addition to his clinical practice, Dr. Hsieh is committed to medical education and has served as an Associate Lecturer and Medical Student Examiner at University of New South Wales (UNSW) School of Medicine from 2021 to 2024, Lecturer for the Victorian Radiation Oncology Training network and an affiliate Senior Lecturer at Deakin University School of Medicine.
Dr Hsieh prioritises personalised care for each individual and takes pride in being approachable, accessible, and contactable. With a personable, down-to-earth communication style, he makes sure that complex medical information is explained clearly, helping patients feel informed and confident in their care.
Publications
Hsieh MT, Fargah F, Tahir ARM, Le NT, Shakespeare TP. Prostate specific membrane antigen PET avidity in a granular cell tumour of the left supraspinatus muscle: a case report. BJR Case Rep. 2024 May 29;10(3):uaae015. doi: 10.1093/bjrcr/uaae015
Hsieh MT, Shakespeare TP, Winkley L, Goonetilleke D, Yap SZL, Tahir ARM. Long-term outcomes of definitive radiation with volumetric modulated arc therapy and concurrent chemotherapy for squamous cell carcinoma of the anus in a regional Australian cancer centre. J Med Imaging Radiat Oncol. 2024 Apr;68(3):325-332.
Hsieh MT, Tustin R, Le T, Mohd Tahir AR, Shakespeare TP. Long-Term Survival After Definitive Concurrent Chemoradiation Therapy for Synchronous Small Cell Neuroendocrine Carcinoma of the Urinary Bladder and Adenocarcinoma of the Prostate: A Case Report. Cureus. 2024 Jan 1;16(1):e51481.
Hsieh MT, Amalaseelan J, Mohd Tahir AR, Le T, Shakespeare TP. No Increase in Acute or Late Radiation Toxicities in Patients With Ehlers-Danlos Syndrome Receiving Adjuvant Breast Radiation Therapy: A Report of Four Cases With Extended Follow-Up. Cureus. 2023 Dec 11;15(12):e50346.
Hsieh MT, Aherne NJ, Ross W, Salindera S, Westhuyzen J, Winkley L, Shakespeare TP. Evaluation of apical clips placed during axillary dissection demonstrates potential under-coverage of axillary radiation therapy target volumes during breast cancer regional nodal irradiation. J Med Imaging Radiat Oncol. 2022 Feb;66(1):158-164.
For a full list of published articles, please click here.